NCT04933916View on ClinicalTrials.gov

Study of EMB-001 as a Potential Smoking Cessation Treatment

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2023

Conditions
Tobacco Use Disorder
Interventions
DRUG

EMB-001

Combination product metyrapone and oxazepam

Trial Locations (2)

27617

Rose Research Center, Raleigh

33014

Embera Site, Miami Lakes

Sponsors
All Listed Sponsors
collaborator

Foundation for a Smoke Free World INC

OTHER

collaborator

Rose Research Center, LLC

INDUSTRY

collaborator

Segal Trials

UNKNOWN

lead

Embera NeuroTherapeutics, Inc.

INDUSTRY